Shaw-Jenq Tsai Selected Research

Vascular Endothelial Growth Factor C

1/2021	Suppression of Extracellular Vesicle VEGF-C-mediated Lymphangiogenesis and Pancreatic Cancer Early Dissemination By a Selective HDAC1/2 Inhibitor.
10/2020	Extracellular vesicle-associated VEGF-C promotes lymphangiogenesis and immune cells infiltration in endometriosis.
1/2020	DUSP2 regulates extracellular vesicle-VEGF-C secretion and pancreatic cancer early dissemination.
6/2015	The non-canonical role of vascular endothelial growth factor-C axis in cancer progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shaw-Jenq Tsai Research Topics

Disease

28	Endometriosis 10/2023 - 05/2002
22	Neoplasms (Cancer) 01/2023 - 01/2005
21	Hypoxia (Hypoxemia) 01/2021 - 01/2005
9	Neoplasm Metastasis (Metastasis) 01/2023 - 12/2008
5	Pathologic Processes 01/2019 - 01/2005
5	Colonic Neoplasms (Colon Cancer) 01/2017 - 09/2011
4	Inflammation (Inflammations) 07/2021 - 01/2017
4	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 12/2008
3	Huntington Disease (Huntington's Disease) 05/2021 - 01/2018
3	Carcinogenesis 01/2013 - 01/2005
3	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 12/2012 - 05/2004
2	Hidradenitis Suppurativa 11/2023 - 11/2021
2	Adenocarcinoma 12/2022 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2020
2	Acne Vulgaris 05/2010 - 01/2005
2	Alopecia (Baldness) 10/2006 - 01/2005
1	Fusobacterium Infections 10/2023
1	Pain (Aches) 01/2019
1	Osteoarthritis 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018
1	Lymphatic Metastasis 06/2015
1	Liver Neoplasms (Liver Cancer) 02/2013
1	Hepatocellular Carcinoma (Hepatoma) 02/2013

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2002
6	Oxygen (Dioxygen)IBA 05/2020 - 12/2008
6	ProstaglandinsIBA 04/2013 - 12/2002
5	Messenger RNA (mRNA)IBA 01/2020 - 05/2002
5	Dinoprostone (PGE2)FDA Link 01/2017 - 12/2002
4	Hormones (Hormone)IBA 11/2021 - 05/2004
4	Estrogens (Estrogen)FDA Link 01/2021 - 12/2002
4	Vascular Endothelial Growth Factor CIBA 01/2021 - 06/2015
4	MicroRNAs (MicroRNA)IBA 01/2020 - 12/2015
4	Oxidoreductases (Dehydrogenase)IBA 09/2011 - 10/2006
3	Phosphotransferases (Kinase)IBA 01/2023 - 02/2013
3	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 07/2021 - 03/2010
3	Fibroblast Growth Factor 9IBA 05/2021 - 01/2018
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021 - 01/2013
3	CytokinesIBA 01/2021 - 01/2005
3	Transcription Factors (Transcription Factor)IBA 07/2017 - 02/2007
3	DNA (Deoxyribonucleic Acid)IBA 12/2015 - 02/2006
3	LeptinIBA 03/2010 - 05/2002
3	steroidogenic acute regulatory proteinIBA 10/2006 - 09/2003
2	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2023 - 01/2013
2	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2017
2	Dual Specificity Phosphatase 2IBA 01/2020 - 01/2017
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2019 - 01/2018
2	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2019 - 09/2011
2	Histones (Histone)IBA 01/2019 - 10/2017
2	ChromatinIBA 01/2018 - 10/2008
2	Interleukin-6 (Interleukin 6)IBA 10/2017 - 12/2011
2	Circular RNAIBA 01/2017 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2017 - 12/2015
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2011 - 01/2005
2	Pyruvic Acid (Pyruvate)IBA 09/2011 - 10/2008
2	Testosterone (Sustanon)FDA Link 05/2010 - 01/2005
2	AndrogensIBA 05/2010 - 01/2005
2	Deferoxamine (Desferal)FDA LinkGeneric 02/2007 - 01/2005
2	EnzymesIBA 10/2005 - 01/2005
1	Interleukin-17 (Interleukin 17)IBA 11/2023
1	transgelinIBA 10/2023
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2023
1	Matrix Metalloproteinases (MMPs)IBA 01/2023
1	Progesterone CongenersIBA 01/2023
1	LigandsIBA 01/2023
1	Progestins (Progestagens)IBA 01/2023
1	dienogest FDA Link 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 12/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	Hyaluronic Acid (Hyaluronan)IBA 07/2021
1	NF-kappa B (NF-kB)IBA 05/2021
1	Hypoxia-Inducible Factor 1IBA 01/2021
1	lenvatinibIBA 10/2020
1	locked nucleic acidIBA 01/2020
1	RNA IsoformsIBA 01/2020
1	ProteomeIBA 03/2019
1	Internal Ribosome Entry SitesIBA 03/2019
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2019
1	Opioid Analgesics (Opioids)IBA 01/2019
1	Lysine (L-Lysine)FDA Link 01/2019
1	anthrax toxin receptorsIBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	Progesterone FDA LinkGeneric 07/2018
1	Progesterone Receptors (Progesterone Receptor)IBA 07/2018
1	LuciferasesIBA 01/2018
1	angiogeninIBA 01/2018
1	COUP Transcription Factor IIIBA 01/2018
1	reparixinIBA 01/2017
1	Histone Deacetylase InhibitorsIBA 01/2017
1	Interleukin-8 (Interleukin 8)IBA 01/2017
1	MethyltransferasesIBA 12/2015
1	AntigensIBA 12/2015
1	5-Methylcytosine (5 Methylcytosine)IBA 12/2015
1	Protein Kinases (Protein Kinase)IBA 07/2014
1	Annexin A2 (Annexin II)IBA 04/2013

Therapy/Procedure

9	Therapeutics 01/2021 - 10/2008
3	Drug Therapy (Chemotherapy) 01/2019 - 05/2011
1	Radiotherapy 01/2019